Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0000919574-26-004022

Stakes reported in this filing

Reporting person Shares Of the class
Domicilium Capital Partners LLC 854,973 19.99%
Daniel Simon 854,973 19.99%
BKJLAGG, LLC 602,266 14.1%
Domicilium Real Estate Fund III LP 238,422 5.9%
Domicilium Real Estate Fund III GP LLC 238,422 5.9%
MSEK Charleston LLC 240,688 5.6%
Bold Stroke Investments, LLC 240,688 5.6%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…